1. Home
  2. EEFT vs MLYS Comparison

EEFT vs MLYS Comparison

Compare EEFT & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Euronet Worldwide Inc.

EEFT

Euronet Worldwide Inc.

HOLD

Current Price

$73.22

Market Cap

3.2B

Sector

Technology

ML Signal

HOLD

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$32.18

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EEFT
MLYS
Founded
1994
2019
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.1B
IPO Year
1997
2023

Fundamental Metrics

Financial Performance
Metric
EEFT
MLYS
Price
$73.22
$32.18
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$111.33
$47.33
AVG Volume (30 Days)
652.0K
1.5M
Earning Date
02-12-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
6.78
N/A
Revenue
$4,182,800,000.00
N/A
Revenue This Year
$8.60
N/A
Revenue Next Year
$7.36
N/A
P/E Ratio
$11.00
N/A
Revenue Growth
7.25
N/A
52 Week Low
$68.56
$8.24
52 Week High
$114.25
$47.65

Technical Indicators

Market Signals
Indicator
EEFT
MLYS
Relative Strength Index (RSI) 41.85 33.08
Support Level $71.83 $31.08
Resistance Level $75.39 $33.64
Average True Range (ATR) 2.09 1.67
MACD -0.21 -0.18
Stochastic Oscillator 18.79 15.11

Price Performance

Historical Comparison
EEFT
MLYS

About EEFT Euronet Worldwide Inc.

Euronet Worldwide Inc is a provider of electronic financial transaction solutions. It offers payment and transaction processing and distribution solutions to financial institutions, retailers, service providers, and individual consumers. The company's product offerings include comprehensive ATM, POS, card outsourcing, card issuing and merchant acquiring services, software solutions, money transfer services, etc. Its reportable operating segments are EFT Processing, epay, and Money Transfer. Maximum revenue is derived from its Money Transfer segment, which provides money transfer services across the world under the brand names Ria, AFEX, IME, and xe. Geographically, the company generates maximum revenue from the United States, followed by Germany, India, France, Greece, and other regions.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: